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314, 322 and 325. Results of lower extremity revascularization for peripheral arterialocclusive disease (PAD) are difficult to analyze because a multi-tude of factors might have a significant effect on outcome. Thesefactors include the following: (1) the indication to intervene (clau-dication, rest pain, or tissue loss); (2) the location or locationsof hemodynamically significant atherosclerotic plaque; (3) the
number of associated arterial segments affected by disease; (4) the diameter of
treated arterial segments; (5) the intervention performed; (6) the type and quality
of the conduit if a bypass graft is performed; and (7) the ability of the patient
and health care team to reduce risk factors (control diabetes, hyperlipidemia, and
hypertension and reduce or stop cigarette smoking). For example, unilateral
inflow disease might involve occlusion or stenosis of the common iliac artery, the
external iliac artery (EIA), or both. Treatment options include axillofemoral, il-
iofemoral, or femoral-femoral bypass grafting; aortobifemoral bypass grafting;
or percutaneous revascularization with angioplasty, stenting, or both. Each
patient might have multiple important issues to consider, and therefore compar-
ing patients while controlling for all these variables is a monumental task.
Despite the obstacles, many investigators have attempted to control the wide
array of variables to determine whether a significant difference in outcomes
exists for men and women. For this article, both surgical infrainguinal revas-
cularization and percutaneous and surgical treatment of aortoiliac occlusive
disease are considered.
Infrainguinal Arterial Bypass Grafting
Most of the studies that examine infrainguinal surgical revascularization in women
are retrospective analyses from a single institution. Unfortunately, this type of study
has resulted in frequent comparisons of dissimilar patient groups (Table 1). 1-6 Only
2 studies compared men and women who had no significant differences regarding
age, smoking history, and incidence of diabetes.5,6 In the other reports, women were
significantly older than men.1-4 The frequency of risk factors, especially smoking
and diabetes mellitus, differed between women and men in most of these article. In
4 reports significantly more men smoked cigarettes.1-4 Diabetes mellitus was more
common in men in one report2 and more common in women in another report,1 and
4 reports did not show a significant difference with respect to diabetes.3-6 Only one
of these article reported the frequency of hyperlipidemia, and no difference was
noted between men and women regarding this risk factor.6
Given the significant differences between the 2 groups being compared in all but
1 of these studies, it is not surprising that outcomes between men and women in
these reports were frequently contradictory. Outcomes were measured in terms of 4
major end points (Table 2).
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Limb Salvage
One study demonstrated statistically significant higher limb
salvage in women 10 years after surgical intervention,1 but
no significant difference was reported in terms of limb
salvage in 4 other studies that reported this outcome.2-4,6
Perioperative Complications and Mortality
All series that reported morbidity identified a significantly
higher wound complication rate for women.1,3,6 One study,
which examined perioperative myocardial infarction, re-
ported a higher rate of this complication in women.5 Peri-
operative mortality did not differ between men and women
in most studies1,2,4-6; however, one study did demonstrate
higher perioperative mortality in men.3
Graft Patency
Overall long-term graft patency did differ in one study,
which identified worse outcomes for women: primary pa-
tency at 1 and 3 years for women was 59% and 54%,
respectively, versus 73% and 70% for men, and secondary
patency at 1 and 3 years for women was 75% and 69%,
respectively, versus 89% and 86% for men.4 Belkin and
colleagues3 identified a statistically significant difference
only when a subset of grafts (those to the tibial vessels)
were evaluated. Secondary patency in these grafts at 5 years
was 70% for women and 81% for men.3 The overall graft
patency in this study was not different for men and women:
primary and secondary patency for women and men were
68% and 74% and 58% and 77%, respectively. No signifi-
cant differences in primary, primary-assisted, and secondary
graft patency between women and men were reported in 4
studies.1,2,5,6
Long-term Survival
Decreased long-term survival was reported in patients with
diabetes (both men and women) in one study.1 Two studies
identified poor long-term survival in women, and this dif-
ference was statistically significant and especially notable
for women with diabetes.4,5 Four studies demonstrated no
difference between men and women regarding long-term
survival.1-3,6
What does all this information mean? In the studies
reviewed, limb-salvage rates did not differ between men and
women. Limb salvage is an important end point because it
is the goal of pursuing treatment of PAD. Similarly, overall
secondary patency rates differed in only one study.4 This
study enrolled women significantly older than the men
TABLE 1. Demographic differences in men and women at the time of infrainguinal surgical revascularization
Reference
No. of
infrainguinal
reconstructions
Diabetes mellitus Age (y) Cigarette smoking
Men Women Men Women Men Women
Roddy and colleagues1 5880 50% 53%* 66 71* 44% 27%*
Harris and colleagues2 823 59% 48%* 65 68* 84% 66%*
Belkin and colleagues3 582 38% 42% 67 71* 60% 47%*
Magnant and colleagues4 381 47% 52% 69 72* 68% 56%*
Mays and colleagues5 165 48% 56% 67 67 71% 66%
Frangos and colleagues6 217 56% 58% 67 69 65% 52%
*P  .05 comparing men with women.
TABLE 2. Outcome differences after infrainguinal revascularization in men and women
Reference
Perioperative
mortality
Perioperative
wound
complications
Length
of
follow-up, y
Limb salvage
Long-term
survival
Secondary graft
patency
M W M W M W M W M W
Roddy and colleagues1 3% 4% 3% 4%* 10 88% 93% 39% 34% 55% 58%
Harris and colleagues2 4% 3% NR NR 5 91% 96% 44% 44% 71%† 67%†
Belkin and colleagues3 3% 1%* 3% 14%* 10 92% 88% 24% 36% 77% 74%
Magnant and colleagues4 2% 4% NR NR 3 89% 82% 72% 54%* 86% 69%*
Mays and colleagues5 2% 5% NR NR 3/5‡ 93% 87% 58% 42%* 98% 97%
Frangos and colleagues6 1% 5% 9% 21%* 5 81% 87% 71% 75% 87% 82%
M, Men; W, women; NR, not reported.
*P  .05 between men and women from the same study.
†Primary patency.
‡Length of limb salvage and graft patency, 3 years; length of survival follow-up, 5 years.
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enrolled in the study at the time of the operation, and the
women experienced significantly reduced long-term sur-
vival when compared with the men. These differences might
contribute to the reduced secondary patencies noted in
women in this study. Roddy and associates1 reported the
largest cohort in this group of studies. Five thousand eight
hundred and eighty infrainguinal reconstructions were re-
viewed in their analysis. No difference was noted in graft
patency between men and women. In addition, the 2 studies
that enrolled men and women with similar demographic
data also reported no significant differences in graft paten-
cy.5,6 Consequently, these studies suggest that probably no
significant difference in long-term patency of infrainguinal
grafts exists between men and women.
A difference in wound complications between men and
women who undergo infrainguinal surgical revasculariza-
tion has been a relatively consistent finding. In addition to
the studies mentioned previously, Nam and coworkers7
specifically examined the issue of wound complications and
identified female sex as an independent risk factor for
incisional complications after infrainguinal vein bypass
grafting. The reasons for this difference are unclear. Perhaps
some metabolic difference exists that predisposes women to
increased wound complications. It also is possible that
women have higher fat content in their soft tissue prone to
ischemia and subsequent poor healing. Important to note is
that this higher complication rate did not translate into a
higher graft occlusion, limb loss, or mortality rate for
women. The clinical effect of this difference is probably
minor when one considers the big picture.
Another important finding from these studies is more
data that suggest coronary artery disease might be more
difficult to diagnose and treat in women. Those women with
diabetes, in particular, might have significant coronary ar-
tery disease undisclosed during routine preoperative screen-
ing, and this might affect perioperative myocardial infarc-
tion and long-term survival. More aggressive approaches,
which include routine invasive testing, might be warranted
in this population.
Aortoiliac Occlusive Disease
Aortobifemoral Bypass Grafting
Surgical treatment of aortoiliac occlusive disease can in-
clude many different procedures. The options generally con-
sidered to be gold standards, especially for diffuse and bilateral
disease, are the aortobifemoral bypass graft and aortoiliac
endarterectomy with patch closure. These procedures are usu-
ally performed with synthetic material (polyester or polytetra-
fluoroethylene). The 5-year patency rates are expected to be
approximately 90%. Unfortunately, there is a lack of data that
examine outcomes of these procedures according to patient
sex. Schneider and colleagues8,9 published 2 reports that did
not demonstrate any difference in primary and secondary graft
patency, 3-year survival, and limb salvage between men and
women who required aortobifemoral bypass. Valentine and
associates10 reported no difference in graft patency or limb
salvage between men and women in a select group of high-risk
patients treated with aortobifemoral bypass graft.
Percutaneous Interventions
Treatment of inflow disease with percutaneous intervention
(angioplasty, stenting, or both) has been accepted widely as
first-line therapy for proximal lower-extremity occlusive
disease. Five-year patency rates are usually reported to be
lower than those for surgical revascularization,11 but com-
plication severity is less, and recovery and in-hospital length
of stay are shorter. Patency rates for percutaneous interven-
tions also are affected significantly by a number of patient
characteristics that include the diameter of the artery treated,
the location of the artery treated (common iliac artery vs
EIA), untreated comorbidities (eg, continued smoking and
untreated hyperlipidemia), and the patency of the distal
vasculature (especially the ipsilateral superficial femoral
artery). Significant differences have been noted in outcomes
between men and women. The patency of iliac artery inter-
vention is lower in women compared with that in men.11,12
Ballard and coworkers11 compared outcomes in stent de-
ployment and surgical reconstruction for aortoiliac occlu-
sive disease. In both univariate and multivariate analysis,
female sex was an independent variable that affected throm-
bosis of both interventions. Timaran and colleagues12 ex-
amined outcomes from iliac angioplasty and stenting only.
They reported that female sex was an independent predictor
of decreased primary patency by using multivariate analy-
sis. EIA intervention also was an independent predictor for
decreased primary patency. Women who had EIA interven-
tion had the worst outcomes (4-fold increase in stent fail-
ure). EIA size, on the basis of the largest balloon used to
perform the intervention, did not differ significantly be-
tween men and women (6.7 vs 6.5 mm). Other significant
predictors of stent failure were smoking and poor runoff
scores. Women who received hormone replacement therapy
(HRT) during the intervention and at follow-up were re-
ported to have significantly lower patency of iliac stents
than women treated similarly who were not receiving HRT
(5-year patency: non-HRT users, 74%; HRT users, 49%).13
Conclusions
When evaluating outcomes in patients with PAD, many
variables should be considered because many different in-
terventions are available, and many different outcome mea-
surements need to be tabulated to make these studies reli-
able. All these considerations create significant obstacles to
the collection of meaningful data. In terms of infrainguinal
revascularization, there do not appear to be significant dif-
ferences between men and women regarding the most impor-
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tant outcome measurements (limb salvage, graft patency, and
mortality). In terms of both surgical and percutaneous treat-
ment of aortoiliac occlusive disease, it is difficult to draw firm
conclusions from the currently available data concerning
whether a true difference exists for outcomes between women
and men. This conclusion is due to the fact that findings from
current studies have not been corroborated.
Future research efforts should address the following:
1. A prospective multi-institutional study has been per-
formed to examine differing outcomes between men
and women with PAD who undergo intervention. This
work needs to be performed for inflow, as well as
infrainguinal, disease and surgical and percutaneous
interventions.
2. Further investigation on the effect of HRT in patients
with PAD is warranted, especially those being treated
with percutaneous techniques.
3. The physiologic basis for wound complications in
women with PAD and potential approaches to im-
prove this problem should be examined.
4. Clinical management changes to improve the long-
term survival of women with diabetes and PAD
should be implemented.
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